Related Experiment Video
Updated: Jan 14, 2026

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
Memantine: updates from the past decade and implications for future novel therapeutic applications
Wojciech Danysz1, Niels Hansen2, Jens Wiltfang2
1Merz Therapeutics GmbH, Eckenheimer Landstraße 100, 60318, Frankfurt am Main, Germany. Wojciech.Danysz@merz.de.
Memantine (a dementia drug) remains effective for Alzheimer's disease. While preclinical studies suggest other uses, further clinical research is needed to confirm efficacy for new indications.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Memantine is an established treatment for Alzheimer's disease.
- Recent advancements have expanded our understanding of its pharmacology and clinical applications over the past decade.
Purpose of the Study:
- To review recent advances in memantine's mechanism of action and efficacy.
- To investigate emerging indications for memantine beyond dementia based on preclinical and clinical data.
Main Methods:
- Comprehensive narrative review of preclinical research and clinical studies.
- Analysis of findings related to memantine's mechanism of action and efficacy in animal models.
- Evaluation of clinical data from Alzheimer's disease patients and off-label studies.
Main Results:
- Memantine demonstrates continued robust efficacy for Alzheimer's disease.
- Preclinical studies indicate potential efficacy in various diseases beyond dementia.
- Limited evidence supports further clinical investigation for these emerging indications.
Conclusions:
- Memantine is a well-established and effective treatment for Alzheimer's disease.
- While promising preclinical data exists for new indications, robust clinical validation is currently limited.
More Related Videos
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression
Antiepileptic Drugs: Glutamate Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...